Hadassah

Hadassah University Medical Center Hosts Bone Marrow Transplant Reunion

Sunday, Jan 15 2012

Two Israeli Arab children who received bone marrow transplants a year ago recently met with their Israeli Arab donors at a reunion hosted by the Hadassah University Medical Center.

The donors are 2 of 65 individuals who were found to be genetically matched to Arab patients in Israel and abroad, thanks to the Bone Marrow Registry created at Hadassah for Arab patients. Eleven of them have already donated their bone marrow and most of the transplantations proved successful.

Hadassah established the registry in October 2008 because 40 percent of Arab patients did not have potential donors and there was no registry for Arabs in the world. It has since been supported by Hadassah Austria and the Kahane Foundation in Austria.

Dr. Amal Bishara manages the registry, together with Prof. Chaim Brautbar, who founded the Hadassah Tissue Typing Unit, and Dr. Shoshana Israel, its current director. Over 15,000 Israeli Arabs joined the registry during more than 90 campaigns in Arab villages and cities in Israel. These campaigns included lectures in Arab colleges and public institutions, as well as ongoing advertisements in Israel's Arab media.

"This was a very moving occasion" said Dr. Bishara. "We are all grateful to the donors, who opened the possibility for new life for people they did not know at all."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More